Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05943756
Other study ID # E-1220-23
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 25, 2023
Est. completion date June 2026

Study information

Verified date October 2023
Source Kessler Foundation
Contact Helen Genova, Ph. D.
Phone 973-324-8390
Email hgenova@kesslerfoundation.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to evaluate the potential benefits of two Intervention programs in adults with TBI to improve well-being and other outcomes that are maintained over time.


Description:

The current study will examine the efficacy of Signature Strengths in adults with TBI to improve self-concept and other outcomes that are maintained over time. Preliminary evidence suggests that after a TBI, an individual can experience significant alteration to their personal identity and a perceived loss of their pre-injury self. By using this Signature Strength intervention, adults with moderate to severe TBI will be able to become aware of their most used "signature" strengths, explore how these strengths are used in everyday life, and apply them in future situations to bring well-being and to better cope with stressors.


Recruitment information / eligibility

Status Recruiting
Enrollment 94
Est. completion date June 2026
Est. primary completion date January 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - At least 18 years of age - Have a diagnosis with moderate to severe TBI - At least one year post injury - Able to speak and read English fluently Exclusion Criteria: - Have a history of multiple sclerosis, stroke, seizures or another nervous system injuries disease in the past (like brain tumor or epilepsy) - Have a significant psychiatric illness (like, schizophrenia or psychosis) - Currently taking steroids and/or benzodiazepines as determined by study staff review of medications - Significant alcohol or drug abuse history (requiring inpatient treatment) - History of stroke, schizoaffective disorder, bipolar disorder, personality disorder or severe depression determined by extensive screening by a trained staff member - Previous participation in a Signature Strengths program

Study Design


Intervention

Behavioral:
Signature Strengths
The treatment group will complete 6 web-based sessions of Signature Strengths(1 sessions per week for 6 weeks), designed to teach lessons focused on the Aware-Explore-Apply interventional framework. Sessions are approximately 60 minutes long.
TBI Education Course
The control group will complete 6 web-based sessions of a TBI Education Course(1 sessions per week for 6 weeks), designed to teach lessons based on the TBI Model Systems Knowledge Translation Center's fact sheets. Sessions are approximately 60 minutes long.

Locations

Country Name City State
United States Kessler Foundation East Hanover New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Kessler Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rosenberg Self-Esteem Scale (RSES) Self-report self-esteem questionnaire. Values range from 10-40, with higher score indicating better outcome. Baseline, 3 months posttest, and 6 months posttest
Primary Strengths Knowledge and Strengths Use Scale (SKUS) Measure to assess knowledge and use of one's strengths and measure changes following strengths-based interventions. Two scores: Strengths Use and Strengths Knowledge. Strengths Use values range from 14-98, with higher score indicating a better outcome. Strengths Knowledge values range from 8-56, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Primary Head Injury Semantic Differential Scale - Version III (HISD-III) Self-report for examination of past and present self-identity. Values range from 18-126, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Primary Global Assessment of Character Strengths 24-item questionnaire to rate levels of individual's character strengths. Values range from 24-120, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Primary Twenty-Statements Task 20-item questionnaire used to measure an individual's self concept filling out the twenty items that each start with the words "I am..." which will be analyzed for positive and negative valence, with higher score indicating a better outcome. There is no maximum or minimum value for this test. Baseline, 3 months posttest, and 6 months posttest
Secondary Flourishing Scale (FS) Measure of well-being and "flourishing". Values range from 8-56, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Secondary Quality of Life After Brain Injury (QOLIBRI) Assess Quality of Life specifically in Brain Injury. Values range from 0-100, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Secondary Satisfaction with Life Scale (SWLS) Measure of life satisfaction. Values range from 5-35, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Secondary Positive and Negative Affect Schedule (PANAS) Measure of both positive and negative emotional feelings. Values range from 10-50, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Secondary Voicemail Elicitation Task Measures how individuals respond to social situations using politeness/impoliteness. Values are calculated by dividing the total number of politeness markers by the total time in minutes, with a higher score indicating a better outcome. There are no minimum or maximum values for this test. Baseline, 3 months posttest, and 6 months posttest
Secondary Perceived Stress Scale 10 item, Self-report measure of perceived stress. Values range from 0-40, with higher score indicating a worse outcome. Baseline, 3 months posttest, and 6 months posttest
Secondary Connor-Davidson Resilience Scale 10 (CD-RISC-10) 10 item self-report measure of resilience. Values range from 0-40, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
Secondary Brain Injury Self-Efficacy Scale 20 item self-report measure of self-efficacy and coping. Values range from 0-80, with higher score indicating a better outcome. Baseline, 3 months posttest, and 6 months posttest
See also
  Status Clinical Trial Phase
Recruiting NCT04526639 - VR Cognitive Rehabiliation for Pediatric TBI N/A
Completed NCT01339702 - The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Not yet recruiting NCT06024122 - Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study
Completed NCT03896789 - Pediatric Guideline Adherence and Outcomes- Argentina N/A
Completed NCT03225768 - Guided Training for People With Cognitive Impairment N/A
Completed NCT04590911 - Effectiveness of Multimodal Cognitive Rehabilitation for Traumatic Brain Injury Sustained During Older Adulthood N/A
Recruiting NCT04121780 - Growth Hormone Replacement Therapy for Retried Professional Football Players Phase 2
Completed NCT04776304 - Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms N/A
Completed NCT00409058 - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI N/A
Completed NCT00205491 - Pharmacological Intervention in Depression After Traumatic Brain Injury Phase 4
Completed NCT03490110 - Brain Markers of Improvements in Cognitive Functioning N/A
Active, not recruiting NCT02525432 - Autologous Stem Cell Study for Adult TBI (Phase 2b) Phase 2
Completed NCT02858544 - Concussion in Motor Vehicle Accidents: The Concussion Identification Index N/A
Completed NCT01728831 - Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury N/A
Recruiting NCT06005194 - InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI N/A
Not yet recruiting NCT05340803 - Sedation of Ventilated Traumatic Brain Injury Patients With Midazolam Alone Versus Combination With Dexmedetomidine or Magnesium Sulfate; Monitored by Ultrasonograghic Optic Nerve Sheath Diameter Phase 3
Recruiting NCT06195345 - Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
Recruiting NCT04279431 - Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One
Completed NCT01948947 - Improving Functions in MTBI Patients With Headache by rTMS N/A